Caribou Biosciences, Inc. Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 5.79M12.36M9.60M13.85M34.48M9.99M
Gross Profit 5.79M12.36M9.60M13.85M34.48M9.99M
Operating items
Research & Development 23.64M34.42M52.26M82.23M112.08M130.15M
Selling, General & Administrative 16.46M14.06M24.32M38.02M38.46M46.46M
Operating Expenses 40.09M48.48M76.58M120.25M150.54M176.61M
Operating Income -34.30M-36.12M-66.98M-106.40M-116.06M-166.62M
EBIT -34.30M-36.12M-66.98M-106.40M-116.06M-166.62M
Non-operating items
Non Operating Investment Income -0.14M
Interest & Investment Income 1.05M0.24M0.15M
Other Non Operating Income 0.51M1.58M4.75M15.47M15.35M
Non Operating Income 3.34M-0.00M0.38M7.05M14.18M17.50M
Net income details
EBT -30.97M-36.13M-66.60M-99.35M-101.88M-149.11M
Tax Provisions -7.54M-1.82M0.32M0.07M0.19M-0.01M
Profit After Tax -23.43M-34.31M-66.92M-99.42M-102.07M-149.10M
Equity Income 2.29M-0.73M-0.13M-0.01M
Income from Continuing Operations -23.43M-34.31M-66.92M-99.42M-102.07M-149.10M
Consolidated Net Income -23.43M-34.31M-66.92M-99.42M-102.07M-149.10M
Income towards Parent Company -23.43M-34.31M-66.92M-99.42M-102.07M-149.10M
Net Income towards Common Stockholders -23.43M-34.31M-66.92M-99.42M-102.07M-149.10M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 51.21M60.19M61.30M88.43M90.55M
Shares Outstanding (Diluted Average) 31.66M60.80M73.81M90.32M
EBITDA -23.43M-34.31M-67.06M-100.80M-100.52M-148.88M
Tax Rate 24.34%5.04%0.01%